Published in Surgery on December 11, 2009
A standard definition of major hepatectomy: resection of four or more liver segments. HPB (Oxford) (2011) 1.03
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg (2012) 1.02
Propensity score analysis demonstrated the prognostic advantage of anatomical liver resection in hepatocellular carcinoma. World J Gastroenterol (2014) 0.96
Robot-assisted parenchymal-sparing liver surgery including lesions located in the posterosuperior segments. Surg Endosc (2011) 0.96
Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size. World J Surg (2015) 0.95
Elevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy. PLoS One (2012) 0.87
Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome. World J Gastroenterol (2014) 0.85
Treatment strategy to improve long-term survival for hepatocellular carcinoma smaller than 5 cm: major hepatectomy vs minor hepatectomy. World J Surg (2014) 0.84
Evaluation of the white test for the intraoperative detection of bile leakage. HPB Surg (2012) 0.84
Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era. World J Surg (2011) 0.83
R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma. World J Surg (2014) 0.81
Anatomic resection of liver segments 6-8 for hepatocellular carcinoma. World J Gastroenterol (2014) 0.79
Resection for hepatocellular carcinoma. J Clin Exp Hepatol (2014) 0.79
Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years. World J Surg Oncol (2014) 0.78
Long-term outcome after liver resection and clinicopathological features in patients with small hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2011) 0.78
Anatomical Resection But Not Surgical Margin Width Influence Survival Following Resection for HCC, A Propensity Score Analysis. World J Surg (2016) 0.78
Ramification of Glisson's sheath peripheral branches and clinical implications in the era of local ablation therapy. Surg Radiol Anat (2010) 0.76
Severity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinoma. World J Surg Oncol (2015) 0.76
Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries. World J Hepatol (2016) 0.75
Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy. PLoS One (2015) 0.75
Impact of multiple liver resections prior to salvage liver transplantation on survival in patients with recurrent HCC. BMJ Open (2015) 0.75
Cardiopulmonary exercise testing for predicting postoperative morbidity in patients undergoing hepatic resection surgery. HPB (Oxford) (2015) 0.75
Liver surgery in cirrhosis and portal hypertension. World J Gastroenterol (2016) 0.75
Impact of glissonean pedicle approach for centrally located hepatocellular carcinoma in mongolia. Int Surg (2015) 0.75
A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma. Clin Transl Gastroenterol (2017) 0.75
Management of centrally located hepatocellular carcinoma: Update 2016. World J Hepatol (2017) 0.75
Central Hepatectomy Still Plays an Important Role in Treatment of Early-Stage Centrally Located Hepatocellular Carcinoma. World J Surg (2017) 0.75
Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. Cancer Res (2012) 1.97
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage. J Hepatol (2009) 1.82
Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology (2010) 1.77
Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J Surg Oncol (2012) 1.63
Predictors of long-term disease-free survival after resection of hepatocellular carcinoma: two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol (2003) 1.60
Adverse outcomes in patients with postoperative ascites after liver resection for hepatocellular carcinoma. World J Surg (2012) 1.56
Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation. Ann Surg Oncol (2011) 1.50
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol (2002) 1.47
Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol (2003) 1.34
Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg (2004) 1.28
Reliability of a new ultrasonic cardiac output monitor in recipients of living donor liver transplantation. Liver Transpl (2008) 1.23
Adenosquamous/squamous cell carcinoma of the gallbladder. J Surg Oncol (2007) 1.16
Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma. PLoS One (2012) 1.10
Scoring short-term mortality after liver transplantation. Liver Transpl (2010) 1.05
Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases. World J Surg (2002) 1.03
Surgical management of giant hepatic hemangiomas: complications and review of the literature. Chang Gung Med J (2012) 1.02
CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection. BMC Cancer (2009) 1.02
Pre-operative risk factors predict post-operative respiratory failure after liver transplantation. PLoS One (2011) 1.00
Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection. Ann Surg (2012) 1.00
Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg (2003) 1.00
ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS One (2008) 0.99
Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin. Ann Surg Oncol (2011) 0.98
The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery (2011) 0.95
Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence? J Gastrointest Surg (2011) 0.95
Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment. World J Surg Oncol (2011) 0.94
Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan. World J Surg (2002) 0.94
Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J Gastroenterol (2009) 0.93
Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome. Asian J Surg (2011) 0.92
Surgical resection of centrally located large hepatocellular carcinoma. Chang Gung Med J (2012) 0.91
Hepatitis C virus infection facilitates gallstone formation. J Gastroenterol Hepatol (2005) 0.91
Preoperative estimation of the liver graft weight in adult right lobe living donor liver transplantation using maximal portal vein diameters. Liver Transpl (2011) 0.90
Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection. Curr Opin Organ Transplant (2014) 0.89
HOXB4 but not BMP4 confers self-renewal properties to ES-derived hematopoietic progenitor cells. Transplantation (2008) 0.89
Liver resection for complicated hepatocellular carcinoma: challenges but opportunity for long-term survivals. J Surg Oncol (2012) 0.87
Adenosquamous carcinoma of the ampulla of Vater - a rare disease at unusual location. World J Surg Oncol (2013) 0.86
Secreted ERBB3 isoforms are serum markers for early hepatoma in patients with chronic hepatitis and cirrhosis. J Proteome Res (2011) 0.86
Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection. World J Gastroenterol (2009) 0.86
Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogastroenterology (2004) 0.85
Prognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis. World J Surg Oncol (2014) 0.85
Differentially profiling the low-expression transcriptomes of human hepatoma using a novel SSH/microarray approach. BMC Genomics (2006) 0.84
Clinical experience of hepatic hemangioma undergoing hepatic resection. Dig Dis Sci (2003) 0.84
Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol (2005) 0.84
Using indocyanine green test to avoid post-hepatectomy liver dysfunction. Chang Gung Med J (2007) 0.84
Application of cryopreserved vein grafts as a conduit between the coronary vein and liver graft to reconstruct portal flow in adult living liver transplantation. Clin Transplant (2009) 0.84
Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate. World J Gastroenterol (2006) 0.84
Clinical perspective of acute humoral rejection after blood type-compatible liver transplantation. Transplantation (2011) 0.83
A case of huge primary liposarcoma in the liver. World J Gastroenterol (2006) 0.83
Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome. Asian J Surg (2011) 0.83
Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome. Ann Surg Oncol (2013) 0.82
Liver cell adenoma with concomitant hepatocellular carcinoma: report of two cases. J Formos Med Assoc (2002) 0.82
Clinical analysis and strategy for liver transplantation in patients with pre-existing portal vein thrombosis. Chang Gung Med J (2011) 0.82
Identification of NV-F virus DNA in hepatocellular carcinoma. J Med Virol (2007) 0.82
The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection. World J Surg Oncol (2013) 0.81
Impact of portal venous hemodynamics on indices of liver function and graft regeneration after right lobe living donor liver transplantation. Liver Transpl (2011) 0.81
Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection. Chang Gung Med J (2005) 0.80
Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma. PLoS One (2013) 0.78
Large fragment pre-S deletion and high viral load independently predict hepatitis B relapse after liver transplantation. PLoS One (2012) 0.78
Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era. Ann Surg (2013) 0.78
Leiomyosarcoma of the adrenal vein. Chang Gung Med J (2012) 0.77
Synthesis and photophysical properties of pyrrole/polycyclic aromatic units hybrid fluorophores. J Org Chem (2010) 0.77
Clinical strategy for the reconstruction of middle hepatic vein tributaries in right liver living donor liver transplantation. World J Surg (2014) 0.77